Atea Pharmaceuticals, Inc.

AVIR

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001593899

SEC filings (opens in a new tab)

No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Atea Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022 All holders in Q1 2022

13F holders of AVIR: Q1 2022 compared with Q2 2022
Measure	Q1 2022	Of which not filed for Q2 2022	Q2 2022	Change
Holders	127	4	128	+5
Shares	54.9M	137.6K	57.5M	+2.69M (+4.9%)
Value	$396.6M	$993.0K	$408.7M	+$13.2M (+3.3%)

4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (22)

Institutions that held Atea Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to AVIR in Q2 2022
Institution	Shares	Value	% of portfolio
K2 Principal Fund, L.P.	1,606,059	$11.4M	1.94%
SG Americas Securities, LLC	65,320	$464.0K	0.01%
New York Life Investment Management LLC	64,590	$459.0K	0.01%
Privium Fund Management (UK) Ltd	61,284	$435.0K	0.49%
Atom Investors LP	30,911	$219.0K	0.10%
Algert Global LLC	25,456	$181.0K	0.01%
Wexford Capital LP	25,000	$178.0K	0.03%
Gsa Capital Partners LLP	25,080	$178.0K	0.03%
Mirae Asset Global Investments Co., Ltd.	20,401	$145.0K	0.00%
Arizona State Retirement System	20,269	$144.0K	0.00%
Blair William & Co	14,439	$103.0K	0.00%
Teacher Retirement System of Texas	14,088	$100.0K	0.00%
Principal Financial Group Inc	13,326	$94.0K	0.00%
ExodusPoint Capital Management, LP	11,727	$83.0K	0.00%
Arrowstreet Capital, Limited Partnership	10,878	$77.0K	0.00%
Ronald Blue Trust, Inc.	8,700	$63.0K	0.00%
Quantbot Technologies LP	1,708	$12.0K	0.00%
Lindbrook Capital, LLC	313	$2.00K	0.00%
Signaturefd, LLC	119	$1.00K	0.00%
Quadrant Capital Group LLC	130	$1.00K	0.00%
Private Capital Group, LLC	156	$1.00K	0.00%
Ellevest, Inc.	29	$0	0.00%

Sold out (17)

Institutions that held Atea Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of AVIR in Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
PDT Partners, LLC	224,660	$1.62M
Simplex Trading, LLC	117,345	$847.0K
Schroder Investment Management Group	104,789	$742.0K
Group One Trading, L.P.	96,049	$693.0K
TD Asset Management Inc	50,853	$367.0K
Capital Fund Management S.A.	35,565	$256.8K
Franklin Resources Inc	23,139	$167.0K
Rafferty Asset Management, LLC	15,774	$114.0K
HSBC Holdings PLC	11,717	$83.0K
Wolverine Trading, LLC	11,487	$81.0K
Bayesian Capital Management, LP	10,800	$78.0K
Jefferies Group LLC	7,500	$54.1K
State of Wyoming	4,700	$34.0K
Walleye Trading LLC	4,232	$31.0K
Federation des caisses Desjardins du Quebec	700	$5.05K
US Bancorp	207	$1.00K
American Portfolios Advisors	100	$722

Not filed for Q2 2022 yet (4)

Institutions that held Atea Pharmaceuticals, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AVIR in Q1 2022 that haven't filed for Q2 2022
Institution	Shares, Q1 2022	Value, Q1 2022
IndexIQ Advisors LLC	56,439	$407.0K
Parametric Portfolio Associates LLC	53,433	$386.0K
Virginia Retirement Systems Et Al	19,600	$142.0K
Amalgamated Financial Corp.	8,080	$58.0K